AVI-4065 Uses, Dosage, Side Effects and more
AVI-4065, a phosphorodiamidate Morpholino oligomer (PMO), is an investigational antisense HCV drug. It was developed by Sarepta Therapeutics, Inc. After phase II trials it was cancelled due to lack of potency.
| Attribute | Details |
|---|---|
| Trade Name | AVI-4065 |
| Generic | AVI-4065 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hepatitis (viral, C).
How AVI-4065 works
AVI-4065 is a virus replication inhibitor (antisense).
